Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Hai-Bo Shao"'
Autor:
Jian Lu, Jin-He Guo, Jian-Song Ji, Yu-Liang Li, Wei-Fu Lv, Hai-Dong Zhu, Jun-Hui Sun, Wei-Xin Ren, Fu-Jun Zhang, Wei-Dong Wang, Hai-Bo Shao, Guang-Shao Cao, Hai-Liang Li, Kun Gao, Po Yang, Guo-Wen Yin, Guang-Yu Zhu, Fa-Zong Wu, Wu-Jie Wang, Dong Lu, Sheng-Qun Chen, Jie Min, Yang Zhao, Rui Li, Li-Gong Lu, Wan Yee Lau, Gao-Jun Teng
Publikováno v:
International Journal of Surgery. 109:1188-1198
Autor:
Ju Zhongjian, Baolin Qu, Hu Ren, Guotong Qiu, Chengfeng Wang, Zongting Gu, Wei Yu, Ke Xu, Jianwei Zhang, Zongze Li, Li-Peng Zhang, Yong-Xing Du, Zhongmin Lan, Hai-Bo Shao, Guang Li
Publikováno v:
Pancreatology. 21:1052-1058
Purpose The purpose of the multi-institutional retrospective study was to evaluate whether intraoperative radiotherapy (IORT) has advantages in the treatment of patients with locally advanced pancreatic cancer (LAPC) compared with concurrent chemorad
Publikováno v:
Hepatology international. 16(6)
Aim To investigate predictors affecting survival in patients with spontaneously ruptured hepatocellular carcinoma (srHCC). Methods One-hundred-and-twenty-seven patients experiencing srHCC between January 2010 and December 2020 were enrolled. The clin
Autor:
Jian Lu, Jin-He Guo, Jian-Song Ji, Yu-Liang Li, Wei-Fu Lv, Hai-Dong Zhu, Jun-Hui Sun, Wei-Xin Ren, Fu-Jun Zhang, Wei-Dong Wang, Hai-Bo Shao, Guang-Shao Cao, Hai-Liang Li, Kun Gao, Po Yang, Guo-Wen Yin, Guang-Yu Zhu, Fa-Zong Wu, Wu-Jie Wang, Dong Lu
Publikováno v:
International Journal of Surgery; May2023, Vol. 109 Issue 5, p1188-1198, 11p
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 14:2491-2494
Background: To evaluate the relative effectiveness of different treatments of hepatocellular carcinoma (HCC) via the hepatic artery. Materials and Methods: The study sample group consisted of 418 patients who were randomly selected from 2008 to 2012
Publikováno v:
World journal of gastroenterology. 21(24)
AIM: To evaluate the prognostic factors in patients with spontaneously ruptured hepatocellular carcinoma (HCC). METHODS: Seventy-nine patients experiencing spontaneous rupture of HCC between April 2004 and August 2014 were enrolled in this study. The
Publikováno v:
Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae. 36(1)
To evaluate the efficacy and safety of the combination of sorafenib and transarterial chemoembolization (TACE)in the treatment of primary hepatocellular carcinoma (HCC).The clinical data of 10 patients with unresectable HCC treated by sorafenib combi
Publikováno v:
Journal of The Electrochemical Society; 2012, Vol. 159 Issue 7, p650-655, 6p
Publikováno v:
Journal of Applied Electrochemistry; Jun2007, Vol. 37 Issue 6, p753-758, 6p, 2 Diagrams, 1 Chart, 6 Graphs
Autor:
Han XJ; Xiang-Jun Han, Hong-Ying Su, Hai-Bo Shao, Ke Xu, Department of Radiology, the First Hospital of China Medical University, Shenyang 110001, Liaoning Province, China., Su HY; Xiang-Jun Han, Hong-Ying Su, Hai-Bo Shao, Ke Xu, Department of Radiology, the First Hospital of China Medical University, Shenyang 110001, Liaoning Province, China., Shao HB; Xiang-Jun Han, Hong-Ying Su, Hai-Bo Shao, Ke Xu, Department of Radiology, the First Hospital of China Medical University, Shenyang 110001, Liaoning Province, China., Xu K; Xiang-Jun Han, Hong-Ying Su, Hai-Bo Shao, Ke Xu, Department of Radiology, the First Hospital of China Medical University, Shenyang 110001, Liaoning Province, China.
Publikováno v:
World journal of gastroenterology [World J Gastroenterol] 2015 Jun 28; Vol. 21 (24), pp. 7488-94.